Association of BDNF G196A Gene Polymorphism with Ischemic Stroke Occurrence and its 6-Month Outcome in an Iranian Population

References

• Azarpazhooh MR, Etemadi MM, Donnan GA, Mokhber N, Majdi MR, Ghayour-Mobarhan M, et al. Excessive incidence of stroke in Iran: Evidence from the Mashhad stroke incidence study(MSIS): A population-based study of stroke in the middle east. Stroke. 2010;41(1):3–10. doi:10.1161/STROKEAHA.109.559708.
   PubMed Web of Science ®Google Scholar
• Delbari A, Salman Roghani R, Tabatabaei SS, Rahgozar M, Lokk J. Stroke epidemiology and one-month fatality among an urban population in Iran. Int J Stroke. 2009;6(3):195–200. doi:10.1111/j.1747-4949.2010.00562.
   Web of Science ®Google Scholar
• Zhao J, Wu H, Zheng L, Weng Y, Mo Y. Brain-derived neurotrophic factor G196A polymorphism predicts 90-day outcome of ischemic stroke in Chinese: A novel finding. Brain Res. 2013;6(1537):312–318. doi:10.1016/j.brainres.2013.08.061.
   Web of Science ®Google Scholar
• Kim JM, Stewart R, Park MS, Kang HJ, Kim SW, Shin IS, et al. Associations of BDNF genotype and promoter methylation with acute and long-term stroke outcomes in an East Asian cohort. PLoS One. 2012;7(12):e51280. doi:10.1371/journal.pone.0051280.
   PubMed Web of Science ®Google Scholar
• Mirowska-Guzel D, Gromadzka G, Czlonkowski A, Czlonkowska A. BDNF −270 C > T polymorphisms might be associated with stroke type and BDNF −196 G > A corresponds to early neurological deficit in hemorrhagic stroke. J Neuroimmunol. 2012;249(1–2):71–75. doi:10.1016/j.jneuroim.2012.04.011
   PubMed Web of Science ®Google Scholar
• Lu H, Zhang T, Wen M, Sun L. Impact of repetitive transcranial magnetic stimulation on post-stroke dysmnesia and the role of BDNF Val66Met SNP. Med Sci Monit. 2015;14(21):761–768. doi:10.12659/MSM.892337.
   Web of Science ®Google Scholar
• Stanne TM, Tjärnlund-Wolf A, Olsson S, Jood K, Blomstrand C, Jern C. Genetic variation at the BDNF locus: Evidence for association with long-term outcome after ischemic stroke. PLoS One. 2014;9(12):e114156. doi:10.1371/journal.pone.0114156.
   PubMed Web of Science ®Google Scholar
• Huang EJ, Reichardt LF. Neurotrophins: Roles in neuronal development and function. Annu Rev Neurosci. 2001;24(1):677–736. doi:10.1146/annurev.neuro.24.1.677.
   PubMed Web of Science ®Google Scholar
• Bath KG, Lee FS. Variant BDNF (Val66Met) impact on brain structure and function. Cogn Affect Behav Neurosci. 2006;6(1):79–85. doi:10.3758/cabn.6.1.79.
   PubMed Web of Science ®Google Scholar
• Almeida RD, Manadas BJ, Melo CV, Gomes JR, Mendes CS, Grãos MM, et al. Neuroprotection by BDNF against glutamate-induced apoptotic cell death is mediated by ERK and PI3-kinase pathways. Cell Death Differ. 2005;12(10):1329–1343. doi:10.1038/sj.cdd.4401662.
   PubMed Web of Science ®Google Scholar
• Schäbitz WR, Schwab S, Spranger M, Hacke W. Intraventricular brain-derived neurotrophic factor reduces infarct size after focal cerebral ischemia in rats. J Cereb Blood Flow Metab. 1997;17(5):500–506. doi:10.1097/00004647-199705000-00003.
   PubMed Web of Science ®Google Scholar
• Egan MF, Kojima M, Callicott JH, Goldberg TE, Kolachana BS, Bertolino A, et al. The BDNF val66met polymorphism affects activity-dependent secretion of BDNF and human memory and hippocampal function. Cell. 2003;112(2):257–269. doi:10.1016/s0092-8674(03)00035-7.
   PubMed Web of Science ®Google Scholar
• Pikula A, Beiser AS, Chen TC, Preis SR, Vorgias D, DeCarli C, et al. Serum brain-derived neurotrophic factor and vascular endothelial growth factor levels are associated with risk of stroke and vascular brain injury: Framingham study. Stroke. 2013;44(10):2768–2775. doi:10.1161/STROKEAHA.113.001447.
   PubMed Web of Science ®Google Scholar
• Singh RB, Takahashi T, Tokunaga M, Wilczynska A, Kim CJ, De Meester F, et al. Effect of brain derived neurotrophic factor, in relation to diet and life-style factors, for prevention of neuropsychiatric and vascular diseases and diabetes. The Open Nutraceuticals Journal. 2014;7(1):5–14. doi:10.2174/1876396001407010005.
   Google Scholar
• Chen A, Xiong LJ, Tong Y, Mao M, et al. The neuroprotective roles of BDNF in hypoxic ischemic brain injury. Biomed Rep. 2013;1(2):167–176. doi:10.3892/br.2012.48.
   PubMedGoogle Scholar
• Hatano S. Experience from a multicentre stroke register: A preliminary report. Bull World Health Organ. 1976;54(5):541–553.
   PubMed Web of Science ®Google Scholar
• Jauch EC, Saver JL, Adams HP, Bruno A, Demaerschalk BM, Khatri P, et al. Guidelines for the early management of patients with acute ischemic stroke a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2013;44(3):870–947. doi:10.1161/STR.0b013e318284056a.
   PubMed Web of Science ®Google Scholar
• Adams HP Jr, Bendixen BH, Kappelle LJ, Biller J, Love BB, Gordon DL, Marsh EE 3rd. Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in acute stroke treatment. Stroke. 1993;24(1):35–41. doi:10.1161/01.str.24.1.35.
   PubMed Web of Science ®Google Scholar
• Kasner SE, Chalela JA, Luciano JM, Cucchiara BL, Raps EC, McGarvey ML, et al. Reliability and validity of estimating the NIH stroke scale score from medical records. Stroke. 1999;30(8):1534–1537. doi:10.1161/01.str.30.8.1534.
   PubMed Web of Science ®Google Scholar
• Oveisgharan S, Shirani S, Ghorbani A, Soltanzade A, Baghaei A, Hosseini S, Sarrafzadegan N. Barthel index in a Middle-East country: Translation, validity and reliability. Cerebrovasc Dis. 2006;22(5–6):350–354. doi:10.1159/000094850.
   PubMed Web of Science ®Google Scholar
• Nasreddine Z. Montreal cognitive assessment (MoCA) version 7.1 May 2010. http://www.mocatest.org/wp-content/uploads/2015/tests-instructions/Moca-Test-Persian.pdf
   Google Scholar
• Sikaroodi H, Majidi A, Samadi S, Shirzad H, Aghdam H, Azimi Kia A. Evaluating reliability of the montreal cognitive assessment test and its agreement with neurologist diagnosed among patients with cognitive complaints. Police Medicine. 2012;1(1):11–17.
   Google Scholar
• Qin L, Kim E, Ratan R, Lee FS, Cho S. Genetic variant of BDNF (Val66Met) polymorphism attenuates stroke-induced angiogenic responses by enhancing anti-angiogenic mediator CD36 expression. J Neurosci. 2011;31(2):775–783. doi:10.1523/JNEUROSCI.4547-10.2011.
   PubMed Web of Science ®Google Scholar
• Dichgans M, Malik R, König IR, Rosand J, Clarke R, Gretarsdottir S, et al. Shared genetic susceptibility to ischemic stroke and coronary artery disease: A genome-wide analysis of common variants. Stroke. 2014;45(1):24–36. doi:10.1161/STROKEAHA.113.002707.
   PubMed Web of Science ®Google Scholar
• Miyajima F, Ollier W, Mayes A, Jackson A, Thacker N, Rabbitt P, et al. Brain-derived neurotrophic factor polymorphism Val66Met influences cognitive abilities in the elderly. Genes Brain Behav. 2008;7(4):411–417. doi:10.1111/j.1601-183x.2007.00363.x.
   PubMed Web of Science ®Google Scholar
• Lu B, Pang PT, Woo NH. The yin and yang of neurotrophin action. Nat Rev Neurosci. 2005;6(8):603–614. doi:10.1038/nrn1726.
   PubMed Web of Science ®Google Scholar
• Pang PT, Teng HK, Zaitsev E, Woo NT, Sakata K, Zhen S, et al. Cleavage of proBDNF by tPA/plasmin is essential for long-term hippocampal plasticity. Science. 2004;306(5695):487–491. doi:10.1126/science.1100135.
   PubMed Web of Science ®Google Scholar
• Cacquevel M, Launay S, Castel H, Benchenane K, Chéenne S, Buée L, et al. Ageing and amyloid-beta peptide deposition contribute to an impaired brain tissue plasminogen activator activity by different mechanisms. Neurobiol Dis. 2007;27(2):164–173. doi:10.1016/j.nbd.2007.04.004.
   PubMed Web of Science ®Google Scholar
• Erickson KI, Kim JS, Suever BL, Voss MW, Francis BM, Kramer AF. Genetic contributions to age-related decline in executive function: A 10-year longitudinal study of COMT and BDNF polymorphisms. Front Hum Neurosci. 2008;2:1–11. doi:10.3389/neuro.09.011.2008.
   PubMed Web of Science ®Google Scholar